TERT Promoter Mutations and Gene Amplification: Promoting TERT Expression in Merkel Cell Carcinoma

Overview

Journal Oncotarget

Specialty Oncology

Date 2014 Oct 11

PMID 25301727

Citations 30

Authors

Hong Xie

Tiantian Liu

Na Wang

Viveca Bjornhagen

Anders Hoog

Catharina Larsson

Weng-Onn Lui

Dawei Xu

Affiliations

Soon will be listed here.

Abstract

Telomerase activation through the induction of its catalytic component TERT is essential in carcinogenesis. The regulatory mechanism and clinical significance underlying cancer-specific TERT expression have been extensively investigated in various human malignancies, but little is known about these in Merkel cell carcinoma (MCC), an aggressive neuroendocrine skin tumor. Here we addressed these issues by determining TERT promoter mutations, gene amplification, mRNA expression and association with clinical variables in MCC. TERT mRNA was expressed in 6/6 MCC cell lines and 41 of 43 tumors derived from 35 MCC patients. Telomerase activity was detectable in all 6 cell lines and 11 tumors analyzed. TERT promoter mutations were identified in 1/6 cell lines and 4/35 (11.4%) MCC cases. The mutation exhibited UV signature and occurred in sun-exposed areas. Increased TERT gene copy numbers were observed in 1/6 cell lines and 11/14 (79%) tumors, and highly correlated with its mRNA expression (r = 0.7419, P = 0.0024). Shorter overall survival was significantly associated with higher TERT mRNA levels in MCC patients (P = 0.032). Collectively, TERT expression and telomerase activity is widespread in MCC, and may be attributable to TERT promoter mutations and gene amplification. Higher TERT expression predicts poor patient outcomes.

Citing Articles

Intron 4-5 hTERT DNA Hypermethylation in Merkel Cell Carcinoma: Frequency, Association with Other Clinico-pathological Features and Prognostic Relevance.

Ricci C, Morandi L, Ambrosi F, Righi A, Gibertoni D, Maletta F Endocr Pathol. 2021; 32(3):385-395.

PMID: 33909215 PMC: 8370894. DOI: 10.1007/s12022-021-09669-y.

Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers.

Harms K, Zhao L, Johnson B, Wang X, Carskadon S, Palanisamy N Clin Cancer Res. 2021; 27(9):2494-2504.

PMID: 33547200 PMC: 8995051. DOI: 10.1158/1078-0432.CCR-20-0864.

Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma-A Retrospective Analysis of a Swedish Cohort.

Bjorn Andtback H, Bjornhagen-Safwenberg V, Shi H, Lui W, Masucci G, Villabona L Cancers (Basel). 2021; 13(2).

PMID: 33445741 PMC: 7828197. DOI: 10.3390/cancers13020265.

Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.

Prieto-Oliveira P Mol Cell Biochem. 2020; 476(2):599-607.

PMID: 33001374 DOI: 10.1007/s11010-020-03929-x.

Merkel Cell Polyomavirus Small T Antigen Activates Noncanonical NF-κB Signaling to Promote Tumorigenesis.

Zhao J, Jia Y, Shen S, Kim J, Wang X, Lee E Mol Cancer Res. 2020; 18(11):1623-1637.

PMID: 32753470 PMC: 7641980. DOI: 10.1158/1541-7786.MCR-20-0587.

References

Huang F, Hodis E, Xu M, Kryukov G, Chin L, Garraway L . Highly recurrent TERT promoter mutations in human melanoma. Science. 2013; 339(6122):957-9. PMC: 4423787. DOI: 10.1126/science.1229259. View

Nicholls C, Li H, Wang J, Liu J . Molecular regulation of telomerase activity in aging. Protein Cell. 2011; 2(9):726-38. PMC: 4875265. DOI: 10.1007/s13238-011-1093-3. View

Scott G, Laughlin T, Rothberg P . Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma. Mod Pathol. 2013; 27(4):516-23. DOI: 10.1038/modpathol.2013.167. View

Straat K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N . Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst. 2009; 101(7):488-97. DOI: 10.1093/jnci/djp031. View

Stoppler H, Stoppler M, Kisiela M, Holzbach A, Moll I, Houdek P . Telomerase activity of Merkel cell carcinomas and Merkel cell carcinoma-derived cell cultures. Arch Dermatol Res. 2001; 293(8):397-406. DOI: 10.1007/s004030100241. View

Horn S, Figl A, Rachakonda P, Fischer C, Sucker A, Gast A . TERT promoter mutations in familial and sporadic melanoma. Science. 2013; 339(6122):959-61. DOI: 10.1126/science.1230062. View

Wang K, Liu T, Liu L, Liu J, Liu C, Wang C . TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas. Oncotarget. 2014; 5(7):1829-36. PMC: 4039120. DOI: 10.18632/oncotarget.1829. View

Kuwamoto S . Recent advances in the biology of Merkel cell carcinoma. Hum Pathol. 2011; 42(8):1063-77. DOI: 10.1016/j.humpath.2011.01.020. View

Shay J, Wright W . Role of telomeres and telomerase in cancer. Semin Cancer Biol. 2011; 21(6):349-53. PMC: 3370415. DOI: 10.1016/j.semcancer.2011.10.001. View

10.

Heidenreich B, Nagore E, Rachakonda P, Garcia-Casado Z, Requena C, Traves V . Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat Commun. 2014; 5:3401. DOI: 10.1038/ncomms4401. View

11.

Harley C . Telomerase and cancer therapeutics. Nat Rev Cancer. 2008; 8(3):167-79. DOI: 10.1038/nrc2275. View

12.

Heidenreich B, Rachakonda P, Hemminki K, Kumar R . TERT promoter mutations in cancer development. Curr Opin Genet Dev. 2014; 24:30-7. DOI: 10.1016/j.gde.2013.11.005. View

13.

Kong F, Zheng C, Xu D . Telomerase as a "stemness" enzyme. Sci China Life Sci. 2014; 57(6):564-70. DOI: 10.1007/s11427-014-4666-6. View

14.

Liu T, Liang X, Bjorkholm M, Jia J, Xu D . The absence of TERT promoter mutations in primary gastric cancer. Gene. 2014; 540(2):266-7. DOI: 10.1016/j.gene.2014.02.051. View

15.

Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R . Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res. 2000; 60(22):6230-5. View

16.

Killela P, Reitman Z, Jiao Y, Bettegowda C, Agrawal N, Diaz Jr L . TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013; 110(15):6021-6. PMC: 3625331. DOI: 10.1073/pnas.1303607110. View

17.

Boukamp P, Mirancea N . Telomeres rather than telomerase a key target for anti-cancer therapy?. Exp Dermatol. 2006; 16(1):71-9. DOI: 10.1111/j.1600-0625.2006.00517.x. View

18.

Duncavage E, Le B, Wang D, Pfeifer J . Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol. 2009; 33(12):1771-7. DOI: 10.1097/PAS.0b013e3181ba7b73. View

19.

Bichakjian C, Lowe L, Lao C, Sandler H, Bradford C, Johnson T . Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007; 110(1):1-12. DOI: 10.1002/cncr.22765. View

20.

Feng H, Shuda M, Chang Y, Moore P . Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008; 319(5866):1096-100. PMC: 2740911. DOI: 10.1126/science.1152586. View